iShares Nasdaq Biotechnology Index (ETF) (IBB): Nibble on the Long Side

Biotech stocks, after some prolonged weakness, are starting to show promising relative and absolute strength. That means opportunity in the IBB. More 

How the Globe’s Dullest Sector is Effortlessly Beating the S&P 500

The utilities sector is the antithesis of high-flying tech stocks, however they are beating the S&P 500 by a wide margin. Here's why to hold utility stocks More 

SPDR S&P 500 ETF Trust: Load up on SPY Insurance While It’s Cheap!

Scoop up some SPY put protection while the sun is shining and options are cheap with a put spread all but guaranteed to thrive. More 

Twitter Inc.: Play a Long Game With a TWTR Stock Trade

Twitter stock price is but a fraction of its prior highs, but now you can profit on the long side with little risk. More 

Earnings Growth Based On Debt and Buybacks? Totally Unsustainable

The biggest abusers of debt today are corporations. The fallout is coming, particularly when it comes to some of the unwise stock buybacks programs in place More 

The Predicament Between Gut Feeling and Actionable Intelligence

You know that moment when you start feeling like something in the market isn't quite right? Here's what to do as you ponder your next moves More 

This Big Biotech ETF Faces a Key Technical Test

Those who follow our blog know we are proponents of technical analysis in reading the trends of the market. A trend in this biotech ETF suggests opportunity More